Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.500
-0.045 (-2.91%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $8.24 million as of April 23, 2025. Its market cap has decreased by -75.53% in one year.
Market Cap
8.24M
Enterprise Value
-14.61M
1-Year Change
-75.53%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $8.24M, a decrease of -56.49%. That is a compound annual growth rate of -24.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 8.24M | -53.93% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.57B |
| UnitedHealth Group | 389.05B |
| Johnson & Johnson | 378.15B |
| AbbVie | 301.01B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 225.27B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |